BIDU: For Better Future Growth, 2019 Is An Investment Year For BIDU Despite Headwind From Macro And Market Competition
BIDU will report 2Q19 results on August 19th after the markets close followed by a 9:15pm EST conference call. Based on our data and calculations, we believe BIDU is likely to deliver 2Q19 net revenue in line with consensus but with better margin. Looking beyond quarterly earnings, we believe 2019 is a changing as well as a challenging year for BIDU. On the one hand, the macro economy is weaker, and competition is stronger; on the other hand, BIDU cleaned up the medical sector, and its feed business has yet to be fully developed.
T.H. Capital is an independent research and investment advisory firm specializing in China. We offers real-time, on-the-ground, bottom-up research across a wide spectrum from macro and industry analysis to company specific projects; from China ADRs to international names that have meaningful exposure to China market. We deliver relevant, comprehensive and data driven research adding immense value to clients.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.